ALHC — Alignment Healthcare, Inc.

Summary of Alignment Healthcare's Q3 2025 Earnings Call

1. Key Financial Results and Metrics

• Health Plan Membership: Grew to 229,600 members, a 26% increase year-over-year.
• Total Revenue: Reached $994 million, up 44% year-over-year.
• Adjusted Gross Profit: Increased to $127 million, a 58% year-over-year growth, with a Medical Benefit Ratio (MBR) of 87.2%, improving by 120 basis points.
• Adjusted SG&A Ratio: Improved to 9.6%, a reduction of 120 basis points year-over-year.
• Adjusted EBITDA: Reported at $32 million, exceeding guidance, with an adjusted EBITDA margin of 3.3%, reflecting a 240 basis point increase year-over-year.
• Cash Position: Ended the quarter with $644 million in cash, cash equivalents, and investments.

2. Strategic Updates and Business Highlights

• Star Ratings: 100% of health plan members are in plans rated 4 stars or above for rating year 2026, significantly outperforming the national average of 63%. Notable achievements include two 5-star contracts in North Carolina and Nevada, and a 4.5-star rating in Texas.
• Operational Investments: Continued investments in back-office automation, clinical engagement, and AVA AI clinical stratification to enhance care delivery and operational efficiency.
• Market Positioning: The company is well-positioned to capitalize on industry disruptions and is focused on maintaining a balance between membership growth and profitability.

3. Forward Guidance and Outlook

• Q4 2025 Guidance:
  • Membership expected between 232,500 and 234,500.
  • Revenue forecasted between $995 million and $1.01 billion.
  • Adjusted gross profit anticipated between $104 million and $113 million.
  • Adjusted EBITDA projected to be between negative $9 million and negative $1 million.
• Full Year 2025 Guidance:
  • Revenue expected between $3.93 billion and $3.95 billion.
  • Adjusted gross profit between $474 million and $483 million.
  • Adjusted EBITDA forecasted between $90 million and $98 million.
• 2026 Growth Expectations: Confident in achieving at least 20% membership growth, supported by early selling season results.

4. Bad News, Challenges, or Points of Concern

• Increased Utilization: Anticipated higher medical utilization in Q4 due to seasonal flu impacts, which could affect MBR.
• Part D Program Changes: Continued caution regarding assumptions related to Part D due to significant changes in the program.
• Competitive Pressures: The Medicare Advantage (MA) market is expected to face headwinds, with some competitors anticipating enrollment declines, which may impact overall market growth.

5. Notable Q&A Insights

• Market Share Dynamics: The company is experiencing strong growth in both gross new adds and retention, with 80-85% of new members switching from other plans.
• M&A Considerations: The company is selectively exploring M&A opportunities, particularly in supplemental benefits, while maintaining a cautious approach to entering new markets.
• Risk Sharing with Providers: Approximately 65-70% of the business is under shared risk arrangements, which have improved clinical and financial outcomes.
• Brand Investment: Plans to invest in brand marketing to enhance member acquisition and reinforce the company’s value proposition in Medicare Advantage.
• RADV Preparedness: The company is well-prepared for potential RADV audits, maintaining strong compliance and documentation processes.

This summary encapsulates the key financial metrics, strategic initiatives, forward guidance, and notable insights from the Q&A, providing a comprehensive overview of Alignment Healthcare's performance and outlook.